Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels

NCT00154193 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart and Lung Transplant

Interventions

DRUG: cyclosporine

Sponsor

Novartis Pharmaceuticals